{
  "success": true,
  "pagesUsed": [
    3,
    7,
    10
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "SYNOPSIS",
        "text": "SYNOPSIS",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "0",
        "sectionTitle": "SYNOPSIS",
        "sectionType": {
          "id": "a4727d33-b7de-4934-a521-3819b6acae8d",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION AND STUDY RATIONALE",
        "text": "INTRODUCTION AND STUDY RATIONALE",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "INTRODUCTION AND STUDY RATIONALE",
        "sectionType": {
          "id": "e9af3daa-331f-4cba-a54a-f260c81bbdc1",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3",
          "nci_2_4"
        ]
      },
      {
        "id": "nc_3",
        "name": "ETHICAL CONSIDERATIONS",
        "text": "ETHICAL CONSIDERATIONS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "ETHICAL CONSIDERATIONS",
        "sectionType": {
          "id": "a5a1280c-47bd-445d-8075-ba75fab0b22f",
          "code": "Ethics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Ethics",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3"
        ]
      },
      {
        "id": "nc_4",
        "name": "INVESTIGATIONAL PLAN",
        "text": "INVESTIGATIONAL PLAN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "INVESTIGATIONAL PLAN",
        "sectionType": {
          "id": "e6712538-e794-4c2d-94d7-1892c44f469b",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4"
        ]
      },
      {
        "id": "nc_5",
        "name": "Efficacy Analyses",
        "text": "Efficacy Analyses",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "8.4.2",
        "sectionTitle": "Efficacy Analyses",
        "sectionType": {
          "id": "bbd2123e-c6e3-446d-88c8-9abe548dd951",
          "code": "Statistics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Statistics",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4"
        ]
      },
      {
        "id": "nc_6",
        "name": "Safety Analyses",
        "text": "Safety Analyses",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "8.4.3",
        "sectionTitle": "Safety Analyses",
        "sectionType": {
          "id": "9cf72ba9-4a8d-4cfe-b1d8-e343dac2abcd",
          "code": "Safety",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Safety",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_7",
        "name": "Interim Analyses",
        "text": "Interim Analyses",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "8.5",
        "sectionTitle": "Interim Analyses",
        "sectionType": {
          "id": "97178fbd-50fd-4799-ab07-b5da32ac932e",
          "code": "Statistics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Statistics",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "STUDY MANAGEMENT",
        "text": "STUDY MANAGEMENT",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "9",
        "sectionTitle": "STUDY MANAGEMENT",
        "sectionType": {
          "id": "e9073fdf-94b8-4af6-95c5-827c39a30beb",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2",
          "nci_8_3"
        ]
      },
      {
        "id": "nc_9",
        "name": "LIST OF ABBREVIATIONS",
        "text": "LIST OF ABBREVIATIONS",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10",
        "sectionTitle": "LIST OF ABBREVIATIONS",
        "sectionType": {
          "id": "e333bad2-d98e-42ed-a70c-4e2ac8a42960",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "RECIST 1.1",
        "text": "RECIST 1.1",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 1",
        "sectionTitle": "RECIST 1.1",
        "sectionType": {
          "id": "64819591-fef0-466e-bf0c-422cae25e5f2",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "CHILD-PUGH SCORE",
        "text": "CHILD-PUGH SCORE",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 2",
        "sectionTitle": "CHILD-PUGH SCORE",
        "sectionType": {
          "id": "57dc3247-2cbb-4336-a0a0-92fa47a6a393",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "ECOG PERFORMANCE STATUS",
        "text": "ECOG PERFORMANCE STATUS",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 3",
        "sectionTitle": "ECOG PERFORMANCE STATUS",
        "sectionType": {
          "id": "dd2cc6d5-d3f4-46ca-a3ae-a75d42e4389e",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_13",
        "name": "NYHA CLASSIFICATION",
        "text": "NYHA CLASSIFICATION",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 4",
        "sectionTitle": "NYHA CLASSIFICATION",
        "sectionType": {
          "id": "52d2b72c-eae3-4a9f-ba08-12d443b6ff48",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_2_1",
        "name": "Introduction",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Introduction"
      },
      {
        "id": "nci_2_2",
        "name": "Research Hypothesis",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Research Hypothesis"
      },
      {
        "id": "nci_2_3",
        "name": "Objectives(s)",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.4",
        "sectionTitle": "Objectives(s)"
      },
      {
        "id": "nci_2_4",
        "name": "Overall Risk/Benefit Assessment",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.6",
        "sectionTitle": "Overall Risk/Benefit Assessment"
      },
      {
        "id": "nci_3_1",
        "name": "Good Clinical Practice",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Good Clinical Practice"
      },
      {
        "id": "nci_3_2",
        "name": "Institutional Review Board/Independent Ethics Committee",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Institutional Review Board/Independent Ethics Committee"
      },
      {
        "id": "nci_3_3",
        "name": "Informed Consent",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Informed Consent"
      },
      {
        "id": "nci_4_1",
        "name": "Study Design and Duration",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Study Design and Duration"
      },
      {
        "id": "nci_4_2",
        "name": "Post-Study Access to Therapy",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Post-Study Access to Therapy"
      },
      {
        "id": "nci_4_3",
        "name": "Study Population",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Study Population"
      },
      {
        "id": "nci_4_4",
        "name": "Concomitant Treatments",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "Concomitant Treatments"
      },
      {
        "id": "nci_5_1",
        "name": "Analysis of OS",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.4.2.1",
        "sectionTitle": "Analysis of OS"
      },
      {
        "id": "nci_5_2",
        "name": "Analysis of ORR",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.4.2.2",
        "sectionTitle": "Analysis of ORR"
      },
      {
        "id": "nci_5_3",
        "name": "Analysis of PFS",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.4.2.3",
        "sectionTitle": "Analysis of PFS"
      },
      {
        "id": "nci_5_4",
        "name": "Analysis of Association between PD-L1 Expression and Efficacy Measures",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.4.2.4",
        "sectionTitle": "Analysis of Association between PD-L1 Expression and Efficacy Measures"
      },
      {
        "id": "nci_8_1",
        "name": "Compliance",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1",
        "sectionTitle": "Compliance"
      },
      {
        "id": "nci_8_2",
        "name": "Records",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2",
        "sectionTitle": "Records"
      },
      {
        "id": "nci_8_3",
        "name": "Clinical Study Report and Publications",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.3",
        "sectionTitle": "Clinical Study Report and Publications"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "CheckMate 459",
        "expandedText": "CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 459",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "HCC",
        "expandedText": "hepatocellular carcinoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "OS",
        "expandedText": "overall survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "ORR",
        "expandedText": "objective response rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "BICR",
        "expandedText": "blinded independent central review",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "RECIST 1.1",
        "expandedText": "Response Evaluation Criteria in Solid Tumors version 1.1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "PFS",
        "expandedText": "progression free survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "PD-L1",
        "expandedText": "Programmed death-ligand 1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "IV",
        "expandedText": "intravenous",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "PO",
        "expandedText": "per os (by mouth)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "BID",
        "expandedText": "bis in die (twice daily)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "q 2w",
        "expandedText": "every 2 weeks",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "HCV",
        "expandedText": "Hepatitis C virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "HBV",
        "expandedText": "Hepatitis B virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "ECOG",
        "expandedText": "Eastern Cooperative Oncology Group",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "NYHA",
        "expandedText": "New York Heart Association",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 13,
      "itemCount": 18,
      "abbreviationCount": 16
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "04",
      "versionDate": "15-Jan-2019",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "CheckMate 459",
          "expansion": "CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 459"
        },
        {
          "abbreviation": "HCC",
          "expansion": "hepatocellular carcinoma"
        },
        {
          "abbreviation": "OS",
          "expansion": "overall survival"
        },
        {
          "abbreviation": "ORR",
          "expansion": "objective response rate"
        },
        {
          "abbreviation": "BICR",
          "expansion": "blinded independent central review"
        },
        {
          "abbreviation": "RECIST 1.1",
          "expansion": "Response Evaluation Criteria in Solid Tumors version 1.1"
        },
        {
          "abbreviation": "PFS",
          "expansion": "progression free survival"
        },
        {
          "abbreviation": "PD-L1",
          "expansion": "Programmed death-ligand 1"
        },
        {
          "abbreviation": "IV",
          "expansion": "intravenous"
        },
        {
          "abbreviation": "PO",
          "expansion": "per os (by mouth)"
        },
        {
          "abbreviation": "BID",
          "expansion": "bis in die (twice daily)"
        },
        {
          "abbreviation": "q 2w",
          "expansion": "every 2 weeks"
        },
        {
          "abbreviation": "HCV",
          "expansion": "Hepatitis C virus"
        },
        {
          "abbreviation": "HBV",
          "expansion": "Hepatitis B virus"
        },
        {
          "abbreviation": "ECOG",
          "expansion": "Eastern Cooperative Oncology Group"
        },
        {
          "abbreviation": "NYHA",
          "expansion": "New York Heart Association"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma",
        "version": "04",
        "versionDate": "15-Jan-2019"
      },
      "sections": [
        {
          "number": "0",
          "title": "SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "1",
          "title": "INTRODUCTION AND STUDY RATIONALE",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Introduction"
            },
            {
              "number": "1.3",
              "title": "Research Hypothesis"
            },
            {
              "number": "1.4",
              "title": "Objectives(s)",
              "subsections": [
                {
                  "number": "1.4.1",
                  "title": "Primary Objectives"
                },
                {
                  "number": "1.4.2",
                  "title": "Secondary Objectives"
                }
              ]
            },
            {
              "number": "1.6",
              "title": "Overall Risk/Benefit Assessment"
            }
          ]
        },
        {
          "number": "2",
          "title": "ETHICAL CONSIDERATIONS",
          "type": "Ethics",
          "subsections": [
            {
              "number": "2.1",
              "title": "Good Clinical Practice"
            },
            {
              "number": "2.2",
              "title": "Institutional Review Board/Independent Ethics Committee"
            },
            {
              "number": "2.3",
              "title": "Informed Consent"
            }
          ]
        },
        {
          "number": "3",
          "title": "INVESTIGATIONAL PLAN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "3.1",
              "title": "Study Design and Duration",
              "subsections": [
                {
                  "number": "3.1.1",
                  "title": "Screening Phase"
                },
                {
                  "number": "3.1.2",
                  "title": "Treatment Phase"
                },
                {
                  "number": "3.1.3",
                  "title": "Follow Up Phase"
                },
                {
                  "number": "3.1.4",
                  "title": "Study Duration"
                },
                {
                  "number": "3.1.5",
                  "title": "Review of Safety"
                },
                {
                  "number": "3.1.6",
                  "title": "Treatment beyond progression"
                }
              ]
            },
            {
              "number": "3.2",
              "title": "Post-Study Access to Therapy"
            },
            {
              "number": "3.3",
              "title": "Study Population",
              "subsections": [
                {
                  "number": "3.3.1",
                  "title": "Inclusion Criteria"
                },
                {
                  "number": "3.3.2",
                  "title": "Exclusion Criteria"
                },
                {
                  "number": "3.3.3",
                  "title": "Women of Childbearing Potential"
                }
              ]
            },
            {
              "number": "3.4",
              "title": "Concomitant Treatments",
              "subsections": [
                {
                  "number": "3.4.1",
                  "title": "Permitted Therapy"
                }
              ]
            }
          ]
        },
        {
          "number": "8.4.2",
          "title": "Efficacy Analyses",
          "type": "Statistics",
          "subsections": [
            {
              "number": "8.4.2.1",
              "title": "Analysis of OS"
            },
            {
              "number": "8.4.2.2",
              "title": "Analysis of ORR"
            },
            {
              "number": "8.4.2.3",
              "title": "Analysis of PFS"
            },
            {
              "number": "8.4.2.4",
              "title": "Analysis of Association between PD-L1 Expression and Efficacy Measures"
            }
          ]
        },
        {
          "number": "8.4.3",
          "title": "Safety Analyses",
          "type": "Safety"
        },
        {
          "number": "8.5",
          "title": "Interim Analyses",
          "type": "Statistics"
        },
        {
          "number": "9",
          "title": "STUDY MANAGEMENT",
          "type": "Other",
          "subsections": [
            {
              "number": "9.1",
              "title": "Compliance"
            },
            {
              "number": "9.2",
              "title": "Records"
            },
            {
              "number": "9.3",
              "title": "Clinical Study Report and Publications"
            }
          ]
        },
        {
          "number": "10",
          "title": "LIST OF ABBREVIATIONS",
          "type": "Other"
        },
        {
          "number": "APPENDIX 1",
          "title": "RECIST 1.1",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX 2",
          "title": "CHILD-PUGH SCORE",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX 3",
          "title": "ECOG PERFORMANCE STATUS",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX 4",
          "title": "NYHA CLASSIFICATION",
          "type": "Appendix"
        }
      ]
    }
  }
}